XWELL, Inc. (XWEL) Fair Value 2026

XWEL · Diagnostics & Research ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.5 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (19/100)

Quick Summary — As of 2026-10-07, XWELL, Inc. (XWEL) trades at $0.80, versus a $1.80 median fair value across its 2 active models — 125.2% above the current price. QOC: 5.5/10. Value Trap Risk: 19/100 (SAFE). 2/13 models active.

Key Facts

Ticker
XWEL
Price
$0.80
Quality Score
5.5/10
Value Trap Risk
19/100
Models Active
2/13
Last Updated
Strength: Dynamic NAV suggests +262.4% upside with 52% confidence
Risk: Limited model coverage (2/13) may reduce confidence

Is XWELL, Inc. (XWEL) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, XWELL, Inc. (XWEL) appears undervalued as of : the median of 2 independent fair value estimates is $1.80, 125.2% above the current price of $0.80. Estimates range from $0.70 to $2.90. XWEL scores 5.5/10 on fundamental quality and 19/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -20.1% versus its own 13-model consensus, across 3,777 rated companies as of 2026-10-07. XWEL’s +125.2% gap is wider than that market norm, and the Diagnostics & Research sector median is -53.3%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy XWELL, Inc. Stock in 2026? →

What Fair Value Does Each Model Give XWEL?

2 Intrinsic Value Models vs. Current Price ($0.80)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · High Conviction
 $2.90 +262.4%
Option-Based · Medium Conviction
 $0.70 -12.1%

All Models Active

All 2 models are displayed above.

What Is XWELL, Inc. (XWEL) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, XWELL, Inc. presents a highly debated valuation profile at its current price of $0.80. The median intrinsic value is estimated at $1.80 (+125.2% median upside), masking a wide model spread between the 1 bullish models and 1 bearish models. Model dispersion is worth noting: Dynamic NAV targets $2.90 (+262.4%), versus PWERM at $0.70 (-12.1%). This +274.4% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About XWEL?

2 of 13 models are currently active for XWEL. Of these, 1 model suggests upside while 1 model suggests overvaluation. Taken together, their median fair value for XWEL is $1.80 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does XWEL Rank in Diagnostics & Research?

Among 50 Diagnostics & Research stocks, XWEL ranks #39 by Quality of Company score. CirclFi's QOC score of 5.5/10 evaluates 32 fundamental signals. A score of 5.5 reflects mixed fundamentals.

The Diagnostics & Research sector introduces analytical considerations specific to biopharma enterprise businesses. For XWELL, Inc., metrics like R&D productivity ratio provide important context that general-purpose valuation models may underweight.

Is XWEL a Value Trap?

CirclFi's Value Trap algorithm assigns XWEL a score of 19/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for XWELL, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, XWELL, Inc. scores 5.5 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +274.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every XWEL valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across XWEL's 2 active models, average confidence is 42%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy XWELL, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Diagnostics & Research Stocks Should You Also Analyze?

10 related Diagnostics & Research stocks with 13-model coverage

OPKOPKO Health, Inc.QOC 5.6ADVBAdvanced Biomed Inc.QOC 5.1QUCYQuantum Cyber N.V.QOC 5.6BIAFbioAffinity Technologies, Inc.QOC 4.9IMDXInsight Molecular Diagnostics Inc.QOC 6.1ISPCiSpecimen Inc.QOC 4.8IDXXIDEXX Laboratories, Inc.QOC 9.5WATWaters CorporationQOC 7.7RDNTRadNet, Inc.QOC 6.6MEDPMedpace Holdings, Inc.QOC 9.3

Read investment analysis: OPK · ADVB · QUCY · BIAF · IMDX · ISPC · IDXX · WAT · RDNT · MEDP

Which Other Stocks Have a Similar Quality Score to XWEL?

7 companies across all industries closest to XWEL’s Quality of Company score of 5.5/10.

BOTYLingerie Fighting Championships, Inc.QOC 5.5AISPAirship AI Holdings, Inc.QOC 5.5BALYBally's CorporationQOC 5.5ELMEElme CommunitiesQOC 5.5MYNDMynd.ai, Inc.QOC 5.5RKDAArcadia Biosciences, Inc.QOC 5.5NVDANVIDIA CorporationQOC 10.0

Read investment analysis: BOTY · AISP · BALY · ELME · MYND · RKDA · NVDA

What Else Do Investors Ask About XWELL, Inc.’s Valuation?

What is XWELL, Inc.'s intrinsic value in 2026?

CirclFi puts XWELL, Inc. (XWEL)'s intrinsic value at $1.80 — the median of 2 independent model estimates as of 2026-10-07, ranging from $0.70 to $2.90. The Quality of Company score is 5.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is XWEL overvalued or undervalued right now?

At $0.80, 1 of 2 active models suggest XWEL may be undervalued, while 1 indicate potential overvaluation. The median of all 2 fair value estimates is $1.80, 125.2% above the current price of $0.80 — a consensus view that XWEL is undervalued. The assessment depends on which methodology best fits XWELL, Inc.'s business model in Diagnostics & Research.

What does a Quality of Company score of 5.5 mean for XWEL?

XWELL, Inc.'s QOC of 5.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on XWEL?

CirclFi analyzes XWEL with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is XWEL a value trap in 2026?

XWELL, Inc.'s Value Trap score is 19/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, XWELL, Inc. (XWEL) has a median fair value of $1.80 — 125.2% above the current price of $0.80 — as of 2026-10-07.” Source: circlfi.com/stock/XWEL/ · Methodology
Primary sources for this XWEL valuation
  • Financial statements: XWELL, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001410428) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for XWEL as of ; valuations recomputed .